Who Buys Ertapenem from India — 137 Importers Behind a $109.0M Market
India's ertapenem import market is served by 137 active buyers who collectively imported $109.0M across 780 shipments. EUGIA US LLC (UNITED STATES) leads with a 14.2% market share, followed by EUGIA US LLC, and AUROMEDICS PHARMA, LLC,. The top 5 buyers together control 46.0% of total import value, reflecting a moderately competitive buyer landscape.
Ertapenem buyer data — 137 importers · $109.0M market · 780 shipmentsTransData Nexus · Indian Customs Data
Top Ertapenem Importers — Ranked by Import Value
EUGIA US LLC (UNITED STATES) is the leading ertapenem importer from India, holding a 14.2% share of the $109.0M market across 780 shipments from 137 buyers. The top 5 buyers — EUGIA US LLC (UNITED STATES), EUGIA US LLC, (UNITED STATES), AUROMEDICS PHARMA, LLC, (UNITED STATES), EUGIA PHARMA (MALTA) LTD, (MALTA), OOOJODAS EXPOIM (RUSSIA) — collectively control 46.0% of total import value.
Top Ertapenem Buyers & Importers
Ranked by import value · 137 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Ertapenem Buyers & Importers — Ranked by Import Value. 137 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Ertapenem — and from which countries?
Flow of Ertapenem exports from India: each country's share and the named importers behind the numbers
Ertapenem — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 88.1% of global Ertapenem imports — led by United States (54.9%) with a total trade value of $109.0M across 780 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $59.9M through 346 shipments. This represents a market share of 54.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EUGIA US LLC - $15.5M (25.8% of country's total business)
• EUGIA US LLC, - $15.0M (25.0% of country's total business)
• AUROMEDICS PHARMA, LLC, - $9.5M (15.8% of country's total business)
• EUGIA US LLC. - $3.6M (6.1% of country's total business)
• EVERSANA LIFE SCIENCE SERVICES - $3.2M (5.3% of country's total business)
• Rest of United States's importers - $13.2M (22.0% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $173.1K, indicating premium pricing strategy compared to the market average of $139.8K.
United States is a key market for Ertapenem imports, representing 54.9% of total trade value.
The importation of Ertapenem from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like EUGIA US LLC and AUROMEDICS PHARMA, LLC in the United States function as intermediaries, procuring large quantities of Ertapenem to supply hospitals, clinics, and pharmacies. Their bulk purchasing often leads to economies of scale, and they typically maintain consistent order patterns to ensure a steady supply chain.
Re-exporters: Companies such as EUGIA PHARMA (MALTA) LTD and APL SWIFT SERVICES (MALTA) LTD in Malta import Ertapenem with the intent to re-export to other markets. Their purchasing behavior is influenced by global demand fluctuations and regulatory environments in target markets, leading to variable order sizes and frequencies.
Contract Manufacturers: Entities like EUGIA PHARMA INDUSTRIA FARMACEUTICA in Brazil import Ertapenem for further processing or formulation. Their procurement is closely tied to production schedules and contractual obligations, resulting in periodic bulk orders aligned with manufacturing cycles.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Import regulations for Ertapenem vary across the top importing countries:
United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Importers must ensure that Ertapenem is FDA-approved and complies with the Federal Food, Drug, and Cosmetic Act. This includes proper labeling, registration of foreign establishments, and adherence to Good Manufacturing Practices (GMP).
Estimated Timeline: The registration process can take several months, depending on the completeness of the application and FDA review times.
Import Tariff/Duty: Pharmaceutical products under HS Code 30042099 are generally duty-free in the U.S., but importers should verify current tariff schedules.
The demand for Ertapenem in importing countries is driven by several factors:
Disease Prevalence: Ertapenem is a broad-spectrum antibiotic used to treat various infections, including complicated intra-abdominal infections, skin infections, and community-acquired pneumonia. The prevalence of these conditions necessitates a steady supply of effective antibiotics.
Government Healthcare Programs: Many countries have implemented programs to combat antimicrobial resistance and ensure the availability of essential antibiotics. For instance, the WHO's Essential Medicines List includes Ertapenem, guiding national procurement strategies.
Universal Health Coverage Expansion: Efforts to expand healthcare access increase the demand for essential medicines. Countries investing in healthcare infrastructure and coverage are likely to see a rise in antibiotic consumption.
Tender-Based Purchasing: Public health systems often procure medicines through competitive tendering processes to ensure cost-effectiveness and supply security. This approach can lead to bulk purchasing agreements for antibiotics like Ertapenem.
Common Questions — Ertapenem Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest ertapenem buyer importing from India?
Based on import volume and value, EUGIA US LLC (UNITED STATES) leads with $15.5M in imports and a 14.2% market share — the highest of any single ertapenem importer. EUGIA US LLC, (UNITED STATES) and AUROMEDICS PHARMA, LLC, (UNITED STATES) are the next largest buyers.
QHow many companies buy ertapenem from India?
There are 137 active ertapenem buyers importing from India, with a combined market of $109.0M across 780 shipments to 46 countries. The top 5 buyers hold 46.0% of total import value, while the remaining 132 buyers handle the other 54.0%.
QWhich countries import the most ertapenem from India?
The top importing countries for ertapenem from India are United States (54.9%), Malta (15.7%), Russia (6.8%), Canada (6.3%), Brazil (4.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of ertapenem, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for ertapenem from India?
The average import transaction value for ertapenem from India is $139.8K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The importation of Ertapenem from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like EUGIA US LLC and AUROMEDICS PHARMA, LLC in the United States function as intermediaries, procuring large quantities of Ertapenem to supply hospitals, clinics, and pharmacies. Their bulk purchasing often leads to economies of scale, and they typically maintain consistent order patterns to ensure a steady supply chain.
Re-exporters: Companies such as EUGIA PHARMA (MALTA) LTD and APL SWIFT SERVICES (MALTA) LTD in Malta import Ertapenem with the intent to re-export to other markets. Their purchasing behavior is influenced by global demand fluctuations and regulatory environments in target markets, leading to variable order sizes and frequencies.
Contract Manufacturers: Entities like EUGIA PHARMA INDUSTRIA FARMACEUTICA in Brazil import Ertapenem for further processing or formulation. Their procurement is closely tied to production schedules and contractual obligations, resulting in periodic bulk orders aligned with manufacturing cycles.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Import regulations for Ertapenem vary across the top importing countries:
United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Importers must ensure that Ertapenem is FDA-approved and complies with the Federal Food, Drug, and Cosmetic Act. This includes proper labeling, registration of foreign establishments, and adherence to Good Manufacturing Practices (GMP).
Estimated Timeline: The registration process can take several months, depending on the completeness of the application and FDA review times.
Import Tariff/Duty: Pharmaceutical products under HS Code 30042099 are generally duty-free in the U.S., but importers should verify current tariff schedules.
The demand for Ertapenem in importing countries is driven by several factors:
Disease Prevalence: Ertapenem is a broad-spectrum antibiotic used to treat various infections, including complicated intra-abdominal infections, skin infections, and community-acquired pneumonia. The prevalence of these conditions necessitates a steady supply of effective antibiotics.
Government Healthcare Programs: Many countries have implemented programs to combat antimicrobial resistance and ensure the availability of essential antibiotics. For instance, the WHO's Essential Medicines List includes Ertapenem, guiding national procurement strategies.
Universal Health Coverage Expansion: Efforts to expand healthcare access increase the demand for essential medicines. Countries investing in healthcare infrastructure and coverage are likely to see a rise in antibiotic consumption.
Tender-Based Purchasing: Public health systems often procure medicines through competitive tendering processes to ensure cost-effectiveness and supply security. This approach can lead to bulk purchasing agreements for antibiotics like Ertapenem.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
2Malta
Malta emerges as the second largest importing country, achieving a total trade value of $17.1M through 115 shipments. This represents a market share of 15.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Malta has a diverse importer base, with their top importers including:
• EUGIA PHARMA (MALTA) LTD, - $5.4M (31.7% of country's total business)
• APL SWIFT SERVICES (MALTA) LTD. - $3.3M (19.5% of country's total business)
• EUGIA PHARMA MALTA LIMITED - $2.2M (12.7% of country's total business)
• EUGIA PHARMA (MALTA) LIMITED - $1.8M (10.6% of country's total business)
• APL SWIFT SERVICES MALTA LTD - $1.6M (9.3% of country's total business)
• Rest of Malta's importers - $2.8M (16.2% of country's total business)
Key Insight: Malta demonstrates strong market positioning with an average shipment value of $149.0K, indicating premium pricing strategy compared to the market average of $139.8K.
Malta is a key market for Ertapenem imports, representing 15.7% of total trade value.
Primary Market
Secondary Market
3Russia
Russia emerges as the third largest importing country, achieving a total trade value of $7.4M through 13 shipments. This represents a market share of 6.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Russia has a diverse importer base, with their top importers including:
• OOOJODAS EXPOIM - $4.8M (65.2% of country's total business)
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $566.7K, indicating premium pricing strategy compared to the market average of $139.8K.
Russia is a key market for Ertapenem imports, representing 6.8% of total trade value.
Primary Market
Secondary Market
4Canada
Canada emerges as the fourth largest importing country, achieving a total trade value of $6.8M through 22 shipments. This represents a market share of 6.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• AURO PHARMA INC - $1.8M (26.6% of country's total business)
• EUGIA PHARMA INC, - $1.3M (18.7% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $310.9K, indicating premium pricing strategy compared to the market average of $139.8K.
Canada is a key market for Ertapenem imports, representing 6.3% of total trade value.
Primary Market
Secondary Market
5Brazil
Brazil emerges as the fifth largest importing country, achieving a total trade value of $4.9M through 21 shipments. This represents a market share of 4.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Brazil has a diverse importer base, with their top importers including:
• EUGIA PHARMA INDUSTRIA FARMACEUTICA - $3.1M (63.1% of country's total business)
Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $232.4K, indicating premium pricing strategy compared to the market average of $139.8K.
Brazil is a key market for Ertapenem imports, representing 4.5% of total trade value.
Primary Market
Secondary Market
TransData Nexus Research · Government and regulatory sources
Mar 2026
Regulatory Authority: Malta Medicines Authority.
Import Registration Process: Importers must obtain a Wholesale Dealer License and ensure that Ertapenem is authorized for sale in Malta. Compliance with the European Medicines Agency (EMA) guidelines is required.
Estimated Timeline: The registration process typically takes 6-12 months, subject to the submission of complete documentation and regulatory review.
Import Tariff/Duty: As an EU member, Malta applies the Common External Tariff; however, pharmaceuticals often benefit from reduced or zero tariffs.
Russia:
Regulatory Authority: Ministry of Health of the Russian Federation.
Import Registration Process: Ertapenem must be registered with the State Register of Medicines. The process involves submitting a dossier, undergoing quality assessments, and obtaining a registration certificate.
Estimated Timeline: The registration process can take 12-18 months, depending on the complexity of the application and regulatory workload.
Import Tariff/Duty: Pharmaceuticals under HS Code 30042099 are subject to import duties, which can vary; importers should consult the latest customs tariff schedules.
Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Importers must obtain a Drug Establishment License and ensure that Ertapenem is authorized under the Food and Drugs Act. Compliance with Good Manufacturing Practices (GMP) is mandatory.
Estimated Timeline: The registration process typically takes 6-12 months, depending on the completeness of the application and regulatory review times.
Import Tariff/Duty: Pharmaceuticals under HS Code 30042099 are generally duty-free in Canada, but importers should verify current tariff schedules.
Brazil:
Regulatory Authority: National Health Surveillance Agency (ANVISA).
Import Registration Process: Ertapenem must be registered with ANVISA, involving the submission of a comprehensive dossier, quality assessments, and compliance with Brazilian pharmacopoeia standards.
Estimated Timeline: The registration process can take 12-24 months, influenced by the complexity of the application and regulatory workload.
Import Tariff/Duty: Pharmaceuticals under HS Code 30042099 may be subject to import duties; importers should consult the latest customs tariff schedules.
Importers are advised to consult the respective regulatory authorities for the most current and detailed information, as regulations and tariffs are subject to change.
TransData Nexus Research · Government and regulatory sourcesMar 2026
With 137 buyers across 46 countries, the market for Ertapenem is diverse and expanding. Manufacturers and exporters should monitor these demand drivers to identify emerging opportunities and tailor their strategies accordingly.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$20.70 per unit
TransData Nexus Research · Government and regulatory sources
Mar 2026
Regulatory Authority: Malta Medicines Authority.
Import Registration Process: Importers must obtain a Wholesale Dealer License and ensure that Ertapenem is authorized for sale in Malta. Compliance with the European Medicines Agency (EMA) guidelines is required.
Estimated Timeline: The registration process typically takes 6-12 months, subject to the submission of complete documentation and regulatory review.
Import Tariff/Duty: As an EU member, Malta applies the Common External Tariff; however, pharmaceuticals often benefit from reduced or zero tariffs.
Russia:
Regulatory Authority: Ministry of Health of the Russian Federation.
Import Registration Process: Ertapenem must be registered with the State Register of Medicines. The process involves submitting a dossier, undergoing quality assessments, and obtaining a registration certificate.
Estimated Timeline: The registration process can take 12-18 months, depending on the complexity of the application and regulatory workload.
Import Tariff/Duty: Pharmaceuticals under HS Code 30042099 are subject to import duties, which can vary; importers should consult the latest customs tariff schedules.
Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Importers must obtain a Drug Establishment License and ensure that Ertapenem is authorized under the Food and Drugs Act. Compliance with Good Manufacturing Practices (GMP) is mandatory.
Estimated Timeline: The registration process typically takes 6-12 months, depending on the completeness of the application and regulatory review times.
Import Tariff/Duty: Pharmaceuticals under HS Code 30042099 are generally duty-free in Canada, but importers should verify current tariff schedules.
Brazil:
Regulatory Authority: National Health Surveillance Agency (ANVISA).
Import Registration Process: Ertapenem must be registered with ANVISA, involving the submission of a comprehensive dossier, quality assessments, and compliance with Brazilian pharmacopoeia standards.
Estimated Timeline: The registration process can take 12-24 months, influenced by the complexity of the application and regulatory workload.
Import Tariff/Duty: Pharmaceuticals under HS Code 30042099 may be subject to import duties; importers should consult the latest customs tariff schedules.
Importers are advised to consult the respective regulatory authorities for the most current and detailed information, as regulations and tariffs are subject to change.
TransData Nexus Research · Government and regulatory sourcesMar 2026
With 137 buyers across 46 countries, the market for Ertapenem is diverse and expanding. Manufacturers and exporters should monitor these demand drivers to identify emerging opportunities and tailor their strategies accordingly.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 137 global importers of Ertapenem identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 780 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 46 destination countries with market share per buyer calculated from capped values.
